نتایج جستجو برای: ret proto

تعداد نتایج: 37432  

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2014
Shuangba He Chun-Hao Chen Natalya Chernichenko Shizhi He Richard L Bakst Fernando Barajas Sylvie Deborde Peter J Allen Efsevia Vakiani Zhenkun Yu Richard J Wong

The ability of cancer cells to invade along nerves is associated with aggressive disease and diminished patient survival rates. Perineural invasion (PNI) may be mediated by nerve secretion of glial cell line-derived neurotrophic factor (GDNF) attracting cancer cell migration through activation of cell surface Ret proto-oncogene (RET) receptors. GDNF family receptor (GFR)α1 acts as coreceptor wi...

Journal: :The Journal of clinical endocrinology and metabolism 2001
R Elisei C Romei T Vorontsova B Cosci V Veremeychik E Kuchinskaya F Basolo E P Demidchik P Miccoli A Pinchera F Pacini

Rearrangements of the RET proto-oncogene may occur in both naturally occurring and radiation-induced papillary thyroid carcinomas. Conflicting results on the frequency and type of RET/PTC rearrangements have been reported in relation to age, radiation exposure, and histological tumor variant. We designed the present study to evaluate in a single laboratory, using the same methodologies, the pat...

Journal: :Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016
Kuniko Sunami Koh Furuta Koji Tsuta Shinji Sasada Takehiro Izumo Takashi Nakaoku Yoko Shimada Motonobu Saito Hiroshi Nokihara Shun-Ichi Watanabe Yuichiro Ohe Takashi Kohno

INTRODUCTION Fusions of the anaplastic lymphoma receptor tyrosine kinase gene (ALK), ret proto-oncogene (RET), ROS proto-oncogene 1, receptor tyrosine kinase gene (ROS1), B-Raf proto-oncogene, serine/threonine kinase gene (BRAF), and neuregulin 1 gene (NRG1) and intronic MMNG HOS Transforming gene (MET) mutations are druggable oncogene alterations in lung adenocarcinoma that cause expression of...

Journal: :cell journal 0
masoumeh mohammadi mehdi hedayati

approximately 5-10% of all thyroid cancers are medullary thyroid carcinomas (mtc). mtc is mainly sporadic in nature, but 20-30% of cases are hereditary. genetic testing for hereditary mtc is very important for the patient and his family, but the patients must be receiving appropriate genetic counseling. about 98% of patients with hereditary mtc have germline mutations in exons 10, 11, 13, 14, 1...

2009
Matthias Krause Dirk Stegemann

Authenti ation Proto ols Matthias Krause and Dirk Stegemann Theoreti al Computer S ien e University of Mannheim Mannheim, Germany Abstra t. The limited omputational resour es available on RFID tags imply a need for spe ially designed authenti ation proto ols. The light weight authenti ation proto ol HB+ proposed by Juels and Weis seems urrently se ure for several RFID appli ations, but is too s...

2017
Maria Sromek Małgorzata Czetwertyńska Magdalena Tarasińska Aneta Janiec-Jankowska Renata Zub Maria Ćwikła Dorota Nowakowska Magdalena Chechlińska

Gain-of-function germline mutations of the RET proto-oncogene are responsible for initiation of carcinogenesis within the thyroid gland and development of hereditary form of medullary thyroid carcinoma and MEN2 syndrome. Genotype-phenotype correlations are established for most RET mutations, but the importance of the synonymous changes in this gene remains debatable. We aimed to analyze RET gen...

Journal: :Molecular medicine reports 2009
Raquel María Fernández Avencia Sánchez-Mejías Maria Macarena Ruiz-Ferrer Manuel López-Alonso Guillermo Antiñolo Salud Borrego

Hirschsprung disease (HSCR) is defined by the absence of intramural ganglia of Meissner and Auerbach along variable lengths of the gastrointestinal tract. Intestinal neuronal dysplasia (IND) type B is characterized by the malformation of the parasympathetic submucous plexus of the gut. A connection appears to exist between these two enteric nervous system abnormalities. Due to the major role pl...

Journal: :Clinical endocrinology 2006
Philippos Kaldrymides Nikolaos Mytakidis Theodore Anagnostopoulos Manolis Vassiliou Athanasia Tertipi Maria Zahariou Theodoros Rampias Giorgos Koutsodontis Irene Konstantopoulou Angela Ladopoulou Thalia Bei Drakoulis Yannoukakos

OBJECTIVE Familial medullary thyroid carcinoma (FMTC) is caused by germ-line mutations in the RET proto-oncogene. These mutations concern mainly cysteine residues in exons 10 and 11, whereas noncysteine mutations in exons 13-16 are rare. Mutations in other exons have been reported only in isolated families. In this study we have analysed the RET gene in two FMTC families negative for mutations ...

2016
Alessia Lopergolo Rosalba Perrone Monica Tortoreto Filippo Doria Giovanni L. Beretta Valentina Zuco Mauro Freccero Maria Grazia Borrello Cinzia Lanzi Sara N. Richter Nadia Zaffaroni Marco Folini

Medullary thyroid cancer (MTC) relies on the aberrant activation of RET proto-oncogene. Though targeted approaches (i.e., tyrosine kinase inhibitors) are available, the absence of complete responses and the onset of resistance mechanisms indicate the need for novel therapeutic interventions. Due to their role in regulation of gene expression, G-quadruplexes (G4) represent attractive targets ame...

2017
Jes Sloth Mathiesen Jens Peter Kroustrup Peter Vestergaard Kirstine Stochholm Per Løgstrup Poulsen Åse Krogh Rasmussen Ulla Feldt-Rasmussen Mette Gaustadnes Torben Falck Ørntoft Thomas van Overeem Hansen Finn Cilius Nielsen Kim Brixen Christian Godballe Anja Lisbeth Frederiksen

BACKGROUND Germline mutations of the REarranged during Transfection (RET) proto-oncogene cause multiple endocrine neoplasia 2 (MEN2). It is unclear whether the distribution of RET mutations varies among populations. The first nationwide study of the distribution of RET mutations was conducted, and the results were compared to those of other populations. METHODS This retrospective cohort study...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید